瑞安房地產(00272.HK)擬進一步發行2億元優先票據
格隆匯 11 月 25日丨瑞安房地產(00272.HK)發佈公告,2020年11月24日,公司及Shui On Development就有關Shui On Development發行新票據,即本金總額美元2億元5.75%於2023年到期的優先票據與瑞士銀行香港分行訂立購買協議,並將作為綠色融資框架下的“綠色債券”發行。新票據將與原有票據合併為單一系列,並就有關票據的所有事宜作為單一系列共同投票。
進一步發行的估計所得款項淨額將約為美元1.99億元。集團擬將發行新票據的所得款項淨額用於為集團根據其綠色融資框架進行的合資格項目提供全部或部分融資或再融資。新票據在新交所上市已獲得原則上批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.